• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


George Bakris, MD

Latest:

Glucose-Lowering Treatment Patterns in Patients With Diabetic Kidney Disease

Real-world treatment of diabetic kidney disease in the United States, based on national-level health care claims and electronic health records data, is inconsistent with the current guidelines.


Ryan Sterling, PhD

Latest:

Factors Associated With Primary Care Physician Turnover in the VA

This longitudinal observational study found higher team satisfaction with workload to be significantly associated with lower primary care physician turnover.


Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI | Image Credit: © Mount Sinai
Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI

Latest:

Renal Denervation Shows Durable Blood Pressure Benefits in Key Trials: Deepak L. Bhatt, MD, MPH, MBA

Renal denervation modestly lowers blood pressure, with durable long-term benefits, according to Deepak L. Bhatt, MD, MPH, MBA.


Jacinda Mawson Nicklas, MD, MPH, MA

Latest:

Additional Clinical Considerations for the Management of Obesity

Panelists discuss how reaching underserved populations requires proactive outreach, digital health tools with appropriate training, addressing health literacy barriers, and ensuring equitable access to diabetes technologies and treatments rather than waiting for patients to seek care.


Christopher Tjoa, MD

Latest:

The Implementation of Opioid Prescribing Report Cards in Medicaid Managed Care: A Community Quality Collaborative

This article describes the Philadelphia Medicaid Opioid Prescribing Initiative that was launched by a multidisciplinary team and mailed local Medicaid providers individualized prescribing report cards.


Giovanni Cucchiaro, MD

Latest:

Preappointment Surveys and Reminder Calls to Improve Show Rate

Patients who completed a preappointment survey were significantly more likely to attend their clinic appointment than noncompleters and spent significantly less time in their appointment.


Terence S. Dermody, MD

Latest:

Consumer-Centric Approach to Enhance Access to Pediatric Specialty Care

The authors’ organization optimized scheduling techniques that improved patient access to pediatric specialists to within 7 calendar days for new patients.


Allison Brennan, MPP

Latest:

CMS Needs to Rethink How Medicare Assesses Quality

Late 2020 changes make accountable care organizations a canary in the coal mine.


Ami Vyas, PhD, MS, MBA

Latest:

Association of Guideline-Concordant Care With Survival, Health Care Utilization, and Costs Among Older Women With Advanced Epithelial Ovarian Cancer

Non–guideline-concordant care for ovarian cancer was associated with higher all-cause and cancer-specific mortality, increased health care utilization, and increased Medicare expenditures, highlighting opportunities for improving cancer care in this vulnerable group.


Milam Ford, BS

Latest:

Reduced Medical Spending Associated With Integrated Pharmacy Benefits

Members covered by an integrated pharmacy benefit (as opposed to a pharmacy carve-out) experienced slower growth in medical spending.


Khrista Achtermann, MHA

Latest:

Managing Total Knee Replacement Under Value-Based Payments

This article describes the approach that a large primary care group at risk for value-based payments chose to deploy in managing clinical and financial outcomes of knee osteoarthritis jointly with orthopedic surgeons.


Crystal Aguh, MD, FAAD

Latest:

Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches

Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.


Jeff Stark, MD | Image Credit: © UCB
Jeff Stark, MD

Latest:

Dr Jeff Stark: New Bimzelx Dose Offers Simplicity and Choice

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.


Emmie Harcourt, MPA

Latest:

Provider Capacity During Medicaid Expansion and a Public Health Emergency

This survey study finds that most Missouri Medicaid providers had capacity for new patients, even during a period of unprecedented Medicaid enrollment growth.


Jamie L. Koprivnikar, MD

Latest:

Financial Considerations Influencing Treatment Strategies in PNH Treatment Pathway

The panelists provide their final thoughts, highlighting financial considerations in PNH treatment.


Katherine Kwon, MD

Latest:

A Standardized Care Pathway Increases Optimal Dialysis Starts

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.


Shipra Singh, MBBS, PhD, MPH

Latest:

Association of Social Risks With Avoiding or Delaying Health Care and With Emergency Department Visits: Evidence From 2017 Ohio Medicaid Assessment Survey

Social risks (food insecurity, housing instability, financial strain, health insurance type) are associated with patients’ decisions to avoid/delay health care and increased utilization of the emergency department.


Monjori Mukerjee, BSc

Latest:

Implementing Team-Based Telemedicine Workflows in Safety-Net Primary Care

Telemedicine in safety-net primary care faces particular challenges. Consistent, team-based workflows can support video visit implementation and health care maintenance in telemedicine visits.


Barry Byrne, MD | image credit: research.pediatrics.med.ufl.edu
Barry Byrne, MD, PhD

Latest:

The Value of Newborn Screening for DMD: Barry Byrne, MD, PhD

Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida, discusses gene therapy considerations for pediatric patients and how newborn screening can influence outcomes for patients with Duchenne muscular dystrophy (DMD).



Olga Anastasia Sawicki, MD, MSc

Latest:

Clinical and Economic Outcomes of a Collaborative Cardiology Care Program

Patients with chronic cardiac conditions benefited from a health care program that strengthened collaboration between general practitioners and cardiology specialists in Baden-Wuerttemberg, Germany.


Veronique Michaud, BPharm, PhD

Latest:

Revisiting Conclusions on the Empiric Segmentation of High-risk Patients

The authors provide feedback on generalizations made regarding interventions for high-risk populations in previous research.


Linda Highfield, PhD

Latest:

The Association of Social Determinants of Health With Health Outcomes

This study explored the statistical association of key social determinants of health with specific health outcomes to validate impact and then created weighted categorical matrices.




Bhavesh Shah, PharmD

Latest:

Impact of Switching Agents in Plaque Psoriasis

The panel details the clinical and economic burden when patients switch between agents in plaque psoriasis.


Image credit: Yale School of Medicine
Onyema Ogbuagu, MBBCh, FACP, FIDSA

Latest:

Lenacapavir Offers Promising Step Forward in HIV Prevention: Q&A With Onyema Ogbuagu, MBBCh, FACP, FIDSA

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across the globe, including in areas where the PURPOSE trials were conducted.


S. Bobby Arelli, MD

Latest:

Effects of Individualized Nurse-Led Care Plans on Olaparib Treatment Duration

A nurse-led personalized care program conducted through a specialty pharmacy prolonged medication persistence among patients with cancer receiving olaparib.


Kardie Tobb, DO, MS

Latest:

Trust Between Patients and Clinicians: An Overlooked and Affordable Approach to Improving US Health Care

Raising the visibility of the importance of trust in patient-clinician relationships can help ensure it is acknowledged and incorporated into policy and tactical considerations.


Pieter Sonneveld, MD, PhD

Latest:

Benefits of Continuing Subcutaneous Daratumumab After Initial Quad Therapy: Pieter Sonneveld, MD, PhD

Pieter Sonneveld, MD, PhD, professor of hematology and chair of the Erasmus MC Cancer Institute in Rotterdam, Netherlands, discussed the continued use of subcutaneous daratumumab following initial treatment, as well as the changing landscape of multiple myeloma treatment.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.